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Abstract 
Process mining helps healthcare professionals understand 
processes within healthcare. While often used in secondary 
care, there is little work in process mining using primary care 
data. Serious adverse events that result from hazardous 
prescribing are common and costly. For example, non-
steroidal anti-inflammatory drugs (NSAIDs) and antiplatelets 
can cause gastro-intestinal bleeds (GiBs). Prescribing typically 
occurs during primary care; therefore we used this setting to 
attempt process mining. We extracted events (drug started, 
drug stopped, GiB) for understanding three prescribing 
pathways, and applied process mining. We found NSAIDs are 
often short-term prescriptions whereas antiplatelets are often 
long-term. This perhaps explains our finding that co-
prescription of gastro-protection is more prevalent for 
antiplatelets than NSAIDs. We identified reasons why primary 
care data is harder to process mine and proposed solutions. 
Process mining primary care data is possible and likely useful 
for improving patient safety and reducing costs. 
Keywords: 
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Introduction 
Process mining describes a collection of methods for extracting 
information about processes from event logs [1]. There are 
three distinct stages: detecting the underlying process from the 
event logs (process discovery); identifying deviations from 
what was expected (conformance checking); and generating 
suggestions for redesigning and improving the processes 
(enhancement) [1]. Process mining adds a temporal dimension 
to standard data mining methods. Originally applied to business 
processes, more recently  has been applied to other domains 
including healthcare. In a recent literature review, we showed 
that while process mining within secondary and tertiary care 
has become more common, there is almost no work within 
primary care [2]. 
Patient safety is fundamental to healthcare systems. Within UK 
primary care this is true for medication prescribing where life-
threatening errors appear in 1 in 550 prescriptions [3]. A recent 
economic analysis showed that: adverse drug reactions (ADRs) 
cost the NHS up to £1.6 billion a year; more than one third of 
ADR related hospital admissions are caused by non-steroidal 
anti-inflammatory drugs (NSAIDs), antiplatelets and 
anticoagulants; and half of the deaths associated with primary 
care ADRs are due to gastro-intestinal bleeds (GiBs) [4]. 
Studying the relationship between the prescribing practice of 
NSAIDs and antiplatelets with ADRs including GiBs is 
therefore important. 
In the UK there are several large databases of coded primary 
care records available for research [5]. While the quality of 
coding may not be universally high [6], all practice-based 
prescribing in primary care is electronic so therefore this would 
be a suitable place to attempt to apply process mining. 
While the epidemiology of hazardous prescribing in primary 
care has been extensively studied using large electronic health 
record databases, to date little is known about the typical 
processes that lead to such prescriptions. To design effective 
interventions for reducing hazardous prescribing, it is essential 
to get a better understanding of these processes. This could lead 
to better decision support systems for prescribers, and 
ultimately improve patient safety and reduce cost by reducing 
the number of ADRs. 
Our objective was therefore to process mine UK primary care 
data to explore the relationship between the prescribing of 
NSAIDs, antiplatelets and the adverse outcome of gastro-
intestinal bleeds. 
Methods 
A process model is a graphical representation of a process 
showing the events and how they interrelate via directed edges. 
Process discovery is the extraction of a process model from an 
event log via the application of an algorithm. There are many 
algorithms with various strengths and weaknesses. For example 
the α-algorithm is simple and therefore easy to undersand, but 
it does not deal well with noisy event logs which are typical of 
real world processes [1]. Heuristic Miner and, in particular, 
Fuzzy Miner are better able to deal with this noise [7]. Here we 
focus on process discovery to prove that process mining can be 
applied to primary care data, and use the Fuzzy Miner to best 
handle the messiness of routinely collected health data. 
Anonymised patient data was obtained from the Salford 
Integrated Record (SIR); a data warehouse with contributions 
from 43 general practices in Salford, UK (population 0.25M). 
All coded data, including diagnoses and medications, for 
patients who have not opted out (1.5% opt outs) was available 
to extract from a SQL Server database. The earliest records are 
historic diagnoses from the 1940s, but the bulk of the data 
collection is from 2000 onwards. Approval was granted by the 
SIR governance board and all data was obtained 
pseudonymised (random identifier, no name, year of birth 
instead of age, geographic region instead of address). 
A review by Spencer et al. [8] identified 56 prescribing safety 
indicators for use in primary care to improve patient safety. 
They each try to prevent a particular adverse outcome through 
safer prescribing, e.g., patients with chronic kidney disease 
should not be prescribed an NSAID because of the increased 
risk of acute renal failure. A subset of these indicators are 
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included in: electronic audit and feedback initiatives such as the  
national PINCER [9] rollout and the SMASH intervention [10]; 
and clinical decision support systems such as OptimizeRx [11]. 
We selected three prescribing safety indicators for further 
analysis that focus on NSAIDs and anticoagulants,  and are 
designed for preventing GiBs in cohorts of patients at increased 
risk such as the elderly and those with a history of peptic 
ulceration. The indicators and the descriptions used in our 
analyses are provided in Table 1. 
Table 1– Prescribing Safety Indicators for Preventing GiBs 
Id Short name Description 
I1 Age≥65 + 
NSAID 
Patients aged 65 and over who are prescribed 
an NSAID should also be prescribed a 
gastro-protective medication (GPM). 
I2 Pep + 
NSAID 
Patients with a history of peptic ulceration 
who are prescribed an NSAID should also be 
prescribed a GPM. 
I3 Pep + 
Antiplatelet 
Patients with a history of peptic ulceration 
who are prescribed an antiplatelet should 
also be prescribed a GPM. 
Prescription events are recorded automatically in a patient’s 
record; however, the stopping of medication is not recorded. 
We have previously developed an algorithm to convert these 
prescription events into more meaningful events such as when 
a drug is started and stopped, and when a dose is changed [12]. 
This process is done by evaluating: the date of the prescription; 
the amount prescribed; and the rate at which it is consumed. For 
the medications of interest (NSAIDs, GPMs, and antiplatelets), 
we extracted the start and stop events. 
For each indicator, we developed queries that would extract the 
patient data. First, we defined the cohort of patients from an 
initial event. For indicator I1, it was when a patient turned 65, 
and for I2 and I3, it was the first instance of a peptic ulceration. 
Next, we extracted the start and stop events for all medications 
of interest. Finally, we extracted other relevant events: GiB and 
peptic ulceration classified as either the first bleed, or a 
subsequent bleed; patient turned 65; and patient died. Clinical 
code sets were constructed for each event of interest [13]. 
The initial output of our medication algorithm gives the start 
and stop events for individual active ingredients so, for 
example, for two different NSAIDs we would have two 
different start events. However, we are only interested in 
whether any NSAID (or other medication) is started if the 
patient is not already taking an existing one. Similarly, when a 
drug is stopped it is only relevant if the patients are then not 
taking any other drug of the same type. An additional 
processing script was therefore required to produce the final 
event log. This additional data processing was done using 
JavaScript and nodejs [14]. 
The data was extracted on 2nd November 2018 and process 
mining was performed by the lead author. Process mining was 
performed using Fluxicon Disco (academic licence) [15] on a 
Dell XPS 15 laptop running Windows 10. All clinical code sets 
and processing code is at https://zenodo.org/record/1493640. 
Results 
The demographic information for the patient cohorts for each 
indicator are displayed in Table 2. The median duration time, 
interquartile range, and number of transitions between events 
are shown in Tables 3-5. For example, in Table 3, the event 
“Bleed” immediately followed the event “Age 65” in the event 
logs 390 times, with a median transition time of 49 (IQR 
[19,112]) months. The process mining diagrams extracted from 
Disco are shown in Figures 1-3. The numbers on the nodes in 
the diagrams represent the number of times each event 
occurred, while the edge numbers are the number of times the 
target event directly followed the source event.  
Table 2– Patient Characteristics for Each Cohort and the 
Population of Salford. Values are n (%) unless otherwise 
specified. 
Demographic I1  I2, I3  All patients 
# of patients 38,936  3,477  270,412 
Age 
  Mean (SD) 
 
76 
 
(8) 
 
66 
 
(16) 
 
37 
 
(23) 
Sex       
  Female 
  Male 
20,633 
18,303 
(53%) 
(47%) 
1,238
2,239 
(36%) 
(64%) 
131,935
138,473 
(49%) 
(51%) 
Ethnicity       
  White 
  Other 
  Unknown 
16,291 
643 
22,002 
(42%) 
(2%) 
(57%) 
1,444 
139 
1,894  
(42%) 
(4%) 
(54%) 
96,696 
24,124 
149,592 
(36%) 
(9%) 
(55%) 
Deprivation [16] 
quintiles 
      
  1st (highest) 
  2nd 
  3rd 
  4th 
  5th (lowest) 
15,023 
8,126 
7,536 
3,533 
4,320 
(39%) 
(21%) 
(19%) 
(9%) 
(11%) 
1,618 
694 
569 
258 
269 
(47%) 
(20%) 
(16%) 
(7%) 
(8%) 
115,593 
56,284 
44,770 
19,591 
19,561 
(43%) 
(21%) 
(17%) 
(7%) 
(7%) 
Table 3– Median Duration in Months of Transitions between 
Key Events for Indicator I1. IQR in [square] brackets. 
Number of transitions in (round) brackets. NSAID – non-
steroidal anti-inflammatory drug, GPM – gastro-protective 
medication. 
Next   
event 
Bl
ee
d 
N
SA
ID
 
(n
o 
G
PM
) 
N
SA
ID
 
(G
PM
) 
N
SA
ID
 
St
op
pe
d 
G
PM
 
St
ar
te
d 
G
PM
 
St
op
pe
d 
Event 
Age 65 49 
[19,112] 
(390) 
33 
[11,74] 
(10925) 
17 
[6,39] 
(1385) 
9 
[2,28] 
(1684) 
48 
[15,111] 
(9366) 
12 
[3,37] 
(1617) 
Bleed 1 
[0,5] 
(523) 
14 
[3,47] 
(48) 
22 
[7,46] 
(75) 
1 
[0,3] 
(54) 
0 
[0,3] 
(582) 
10 
[2,34] 
(276) 
NSAID 
(no 
GPM) 
6 
[1,36] 
(34) 
  1 
[1,3] 
(24106) 
0 
[0,0] 
(9478) 
 
NSAID 
(GPM) 
2 
[1,32] 
(11) 
  1 
[1,3] 
(8733) 
 1 
[1,5] 
(566) 
NSAID 
Stopped 
20 
[5,57] 
(292) 
11 
[5,26] 
(14923) 
10 
[5,22] 
(4553) 
 18 
[5,46] 
(6913) 
0 
[0,5] 
(7769) 
GPM 
Started 
5 
[1,23] 
(483) 
 9 
[3,27] 
(3966) 
1 
[1,2] 
(6548) 
 1 
[1,5] 
(28868) 
GPM 
Stopped 
13 
[3,38] 
(231) 
11 
[5,25] 
(5719) 
 1 
[1,4] 
(2724) 
6 
[2,14] 
(21444) 
 
For indicator I1 there were 45,479 NSAID start events. Of 
these, 9,981 (22%) were for patients already prescribed a GPM. 
A further 9,478 (21%) then started GPM at a median duration 
of 0 days suggesting co-prescription. However, 24,106 (53%) 
NSAID start events were followed by an NSAID stop event at 
a median duration of 1 month (IQR [1, 3] months), suggesting 
a short term prescription without co-prescription of a GPM. 
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Figure 1– Process Diagram for Indicator I1. 
 NSAID – non-steroidal anti-inflammatory drug, GPM – 
gastro-protective medication.  
Table 4– Median Duration in Months of Transitions between 
Key Events for Indicator I2. IQR in [square] brackets. 
Number of transitions in (round) brackets. NSAID – non-
steroidal anti-inflammatory drug, GPM – gastro-protective 
medication. 
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ID
 
St
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d 
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G
PM
 
St
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Event 
Initial 
Bleed 
3 
[0,60] 
(603) 
154 
[46,283] 
(564) 
  2 
[1,71] 
(2102) 
 
Bleed 2 
[1,7] 
(752) 
57 
[17,107] 
(125) 
18 
[4,52] 
(88) 
1 
[0,8] 
(21) 
1 
[0,24] 
(729) 
5 
[1,24] 
(299) 
NSAID 
(no 
GPM) 
1 
[0,6] 
(14) 
  1 
[1,2] 
(2388) 
0 
[0,1] 
(861) 
 
NSAID 
(GPM) 
5 
[1,27] 
(11) 
  1 
[1,3] 
(1416) 
 2 
[1,5] 
(112) 
NSAID 
Stopped 
15 
[4,38] 
(157) 
14 
[7,30] 
(1437) 
11 
[6,25] 
(695) 
 13 
[4,36] 
(910) 
1 
[0,11] 
(912) 
GPM 
Started 
4 
[1,19] 
(501) 
 13 
[4,33] 
(819) 
1 
[1,3] 
(630) 
 2 
[1,7] 
(6884) 
GPM 
Stopped 
9 
[3,27] 
(226) 
13 
[6,33] 
(1147) 
 1 
[0,3] 
(305) 
6 
[3,14] 
(5551) 
 
 
 
Figure 2– Process Diagram for Indicator I2. NSAID – non-
steroidal anti-inflammatory drug, GPM – gastroprotective 
medication. 
Similar results were found in indicator I2 when out of 6,368 
NSAIDs, 25% (1,602) were for patients with a pre-existing 
GPM, 14% (861) were followed almost instantly by a GPM, 
and 38% (2,388) were for a short-term prescription without a 
GPM. The results for indicator I3 suggest that GPMs are more 
frequently co-prescribed with APs with only 22% of AP start 
events (513 out of 2309), neither having a pre-existing GPM or 
immediately followed by a GPM. 
The event most likely to precede a GiB or peptic ulceration is a 
previous GiB or peptic ulceration. This is to be expected as it is 
known that a strong predictor of gastro-intestinal adverse 
events is a previous bleed or ulceration.  
Table 5– Median Duration in Months of Transitions between 
Events for Indicator I3. IQR in [square] brackets. Number of 
transitions in (round) brackets. AP – antiplatelet, GPM – 
gastro-protective medication. 
Next   
event 
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A
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 (n
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G
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A
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 (G
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A
P 
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op
pe
d 
G
PM
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d 
G
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pe
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Event 
Initial 
Bleed 
3 
[0,77] 
(621) 
78 
[1,287] 
(390) 
  4 
[1,120] 
(2197) 
 
Bleed 2 
[1,7] 
(758) 
39 
[2,122] 
(81) 
12 
[4,54] 
(52) 
11 
[2,40] 
(59) 
1 
[0,35] 
(761) 
5 
[1,24] 
(286) 
AP (no 
GPM) 
7 
[1,36] 
(33) 
  2 
[1,7] 
(451) 
0 
[0,6] 
(851) 
 
AP 
(GPM) 
7 
[2,24] 
(51) 
  5 
[1,25] 
(482) 
 8 
[2,31] 
(160) 
AP 
Stopped 
7 
[1,23] 
(30) 
6 
[2,13] 
(326) 
6 
[2,14] 
(353) 
 8 
[3,29] 
(181) 
0 
[0,6] 
(480) 
GPM 
Started 
5 
[1,25] 
(525) 
 14 
[2,47] 
(540) 
7 
[2,26] 
(445) 
 2 
[1,7] 
(7337) 
GPM 
Stopped 
10 
[3,33] 
(246) 
10 
[2,31] 
(566) 
 4 
[1,21] 
(144) 
7 
[4,18] 
(6165) 
 
Figure 3– Process Diagram for Indicator I3. AP – 
antiplatelet. GPM – gastro-protective medication. 
The median duration of NSAID and GPM prescriptions is 1 
month, suggesting that these medications are typically short-
term. Antiplatelets are prescribed at a median length of 5 
months and 2 months for patients with and without a pre-
existing GPM respectively, suggesting longer term 
prescriptions. 
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Discussion 
Summary of findings and comparison to existing literature 
Little published work on process mining in primary care exists 
[2]: Dagliati et al. [17] used primary care data to investigate 
care pathways related to cardiovascular risk of Type II diabetes 
patients. However, the majority of their data was obtained from 
secondary care. Another paper used primary care data, but 
didn’t report any results [18]. A further 4 papers used insurance 
data [19–22] which probably included primary care data, but 
also secondary care and tertiary care data. Also, the level of data 
included in insurance datasets is different to that which is 
routinely collected in primary care for the provision of care. To 
the best of our knowledge, the process mining performed for 
this paper is the first performed exclusively using primary care 
electronic health data. 
A GPM was more likely to be co-prescribed to patients 
receiving a course of antiplatelets than it was to those receiving 
NSAIDs. The difference in prescription lengths is one possible 
explanation. When a clinician prescribes a short-term NSAID 
course, perhaps in response to an acute injury or minor illness, 
he/she may decide the risk is small enough that co-prescription 
of a GPM is unnecessary. However, when prescribing a longer-
term course, the risk is increased. This might also be true for 
those on longer courses of NSAIDs for chronic pain conditions. 
Stratifying medications depending on whether they are short or 
long term might give further insight into clinicians’ behaviour. 
GPMs such as proton pump inhibitors can be prescribed for a 
variety of reasons. For treating an active bleed, to manage the 
symptoms of gastrointestinal irritation of reflux, or 
prophylactically for patients at high risk of a bleed – especially 
when increased because of other medications. Attempting to 
stratify the GPM events accordingly could again lead to more 
understanding of prescribing behaviour. 
Implications for practice and research 
In order to achieve our results, there were several challenges 
that needed to be overcome which could explain why process 
mining in secondary care is more prevalent. 
Data quality 
The quality of healthcare data is limited for many reasons. 
Events can be incorrectly recorded, unrecorded, or uncoded. All 
of which limit the confidence and utility of any results 
generated. Researchers must try and understand the limitations 
in their data to make best use of it. Primary care data can be 
thought of as snapshots of coded information that are generated 
on every contact with the health system. This is different for 
inpatient secondary care where the entire duration of treatment 
can be observed and recorded. 
While many events recorded in a primary care system may have 
uncertain veracity, the generation of a prescription is an event 
we can mine with confidence because, in the UK, virtually all 
prescriptions are electronically generated in primary care. This 
is not true for the adverse event of bleeding which may occur 
in secondary care and may not be coded in the primary care 
record. To mitigate against this, linked primary and secondary 
data would be required, and is another reason why process 
mining exclusively in primary care is not done. Future work 
should focus on pathways that occur almost exclusively in 
primary care such as the diagnosis, monitoring and treatment of 
certain chronic conditions such as hypertension. 
Start and end points 
Within secondary care, the start of a process can clearly be 
defined as the admission to hospital, while the end of the 
process is discharge or death. A patient visiting hospital more 
than once can be treated as two separate pathways. Within 
primary care, processes are often cyclical and entangled with 
other processes. Taking indicator I2 as an example, should the 
start event be the first instance of peptic ulceration, or should it 
be the first prescription of an NSAID in a patient with previous 
peptic ulceration? The former means that each patient only has 
one pathway, but with potentially multiple cycles, while the 
latter separates each NSAID prescription into a separate 
process but then doesn’t take the patient’s history into account. 
Detailed consideration must be given to determine whether the 
primary care processes under analysis have well defined end 
points, and queries structured to separate data into these 
individual processes. 
Event granularity  
The coded events within primary care are not necessarily the 
events that should make up the event log on which process 
mining depends. An example is medications where the patient 
record contains the prescription events, whereas the events of 
interest on a care pathway would be when the clinician has 
started, stopped, or altered the dosage of a medication. This is 
also true for measurements, where a series of blood pressure 
(BP) values do not necessarily constitute events, but the 
occurrence of two systolic BPs >140 mmHg within two weeks 
might be a trigger to investigate a diagnosis of hypertension and 
could therefore be considered an event to process mine. 
However, this introduces a bias as the researcher must decide a 
priori what constitutes an event. Is it that a BP was taken, that 
the BP was high or that some combination of values was 
measured over a certain period of time? Careful consideration 
must be made to convert the raw data into an event log, but this 
is not straightforward and is largely subjective. 
Medications 
The lack of a stop event for medications requires an extra 
processing step to determine when a patient’s medication has 
expired. There is also no way of knowing whether a medication 
once collected is in fact consumed by the patient, or if the 
patient is using over the counter medications. This is less of an 
issue in inpatient secondary care when the both the prescription 
and administration of medication can be monitored and 
recorded. 
Memory 
The process mining diagrams that we have produced are 
heuristic nets which are memory-less: each transition in the 
process map is taken in isolation without consideration of prior 
events. By redefining the start events of NSAID and 
antiplatelets to take into account whether a GPM was already 
prescribed allowed us to introduce an element of memory into 
the system. This is useful to better understand the various 
pathways, however future work using other process mining 
modelling techniques, such as causal nets [23], might produce 
better results. 
Conclusions 
Primary care data in the UK has reliably coded prescribing 
information and process mining can be successfully applied 
leading to results that may be useful for clinical decision 
support systems and improving patient safety. 
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However primary care data presents several unique challenges. 
Careful pre-processing must first be undertaken, but this is 
subjective and must therefore be sensibly performed and 
meticulously recorded in order to facilitate scrutiny and 
reproducibility. The use of a clinical reference group to review 
and confirm data quality and provide insight into the direction 
of research would be beneficial. Other more powerful process 
mining and machine learning techniques could be applied now 
that the initial problems with primary care data have been 
considered and to some extent addressed. 
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